Cryo-Cell International, Inc. announced earnings results for the second quarter ended May 31, 2012. For the quarter, consolidated revenues for the second quarter of fiscal 2012 were approximately $4.4 million compared to approximately $4.6 million for the second quarter of fiscal year 2011. The company reported a net loss for the three months ended May 31, 2012 of approximately $3.2 million or $0.28 per basic share, compared to net income of approximately $177,000, or $0.01 per diluted share for the three months ended May 31, 2011. The decrease in net income for the three months ended May 31, 2012 was principally due to a 59% increase in selling, general and administrative expenses, due mainly to an increase of $726,000 in stock option compensation and the increase in sales and marketing initiatives. The company announced that it certainly expects to be profitable for the fiscal year 2013.